Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px
Organisation › Details

Odyssey Therapeutics Inc.

Odyssey Therapeutics is a biotechnology company focused on discovering, developing and commercializing the next generation of immunomodulators and oncology medicines. Composed of an expert team of drug hunters, scientists and industry leaders in foundational biology, chemistry and data sciences, Odyssey is transforming drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. *

 

Period Start 2021-12-07 existent
  Group Odyssey Therapeutics (Group)
Products Industry immuno modulatory compound (IMO)
  Industry 2 cancer drug
Persons Person Glick, Gary D. (Odyssey Therapeutics 202112 CEO + Co-Founder before Scorpion Therapeutics + IFM Therapeutics)
  Person 2 Gordon, Carl L. (OrbiMed Advisors 201509 Partner)
     
Region Region Boston, MA
  Country United States (USA)
  Street 51 Sleeper Street
  City 02210 Boston, MA
  Tel +1-617-865-9628
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA.
     
   
Record changed: 2023-12-08

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Odyssey Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top